 |
 |
| You are here: Home
> IN DEPTH |
| |
|
|
 |
| SEZ |
|
Starting block |
Can India's Rs 4,800-crore
private special economic zone compete
with its Chinese counterparts?
Read
>> |
|
|
|
|
|
| Pathology
labs |
| Still
in the lab |
After the first phase
of corporatisation, the business of
pathology is at the crossroads once
again. The six leaders that emerged
from the first phase are left with less
scope for differentiation in an extremely
fragmented business. They are now desparate
for newer paths of growth. A look at
the possibilities the Super Six are
exploring.
Read
>> |
|
|
|
|
|
|
|
|
| ITTIAM
systems |
| The
3rd option |
The company has successfully
executed the IP-licensing model, something
unprecedented in India. How feasible
is this for companies in the country
that are used to the conventional products
and services route.
Read
>> |
|
|
|
|
|
|
| |
|
| |
|
|
